Dr. Steve Cutler

Chief Executive Officer
immunology
Immunocellular Therapeutics
Belarus

Business Expert Immunology
Biography

Dr. Steve Cutler was appointed Chief Executive Officer of ICON plc in March 2017 having previously served as Chief Operating Officer from January 2014 to March 2017. Dr. Cutler served as Group President, Clinical Research Services from November 2011 until his appointment as Chief Operating Officer.  Dr. Cutler was appointed to the Board of Directors in November 2015.

Research Intrest

Prior to joining ICON, Dr. Cutler held the position of Chief Executive Officer of Kendle having previously served as Chief Operating Officer. Prior to Kendle, Dr. Cutler spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management - Europe; and Vice President, Oncology - Europe as well as regional leadership positions in South Africa and Australia. Prior to joining Quintiles, Dr. Cutler held positions with Sandoz (now Novartis) in Australia and Europe.